Medtronic Plc MDT

Revenue Intelligence Report • 36 quarters of SEC filing data • Updated 2026-03-06

Medtronic Plc demonstrates a strong correlation between its selling, general, and administrative (SG&A) expenses and revenue growth, with a 1% increase in SG&A resulting in a 1.04% increase in revenue, indicating effective investment in these areas. The company's latest quarterly revenue of $9,017 million reflects its robust market position, supported by a solid model accuracy of 2.0% MAPE. Looking ahead, Medtronic is forecasting a revenue of $36 billion for the fiscal year, representing a 3.5% year-over-year growth, which suggests a positive outlook driven by strategic spending and operational efficiencies. Investors can expect a favorable return on investment as the company continues to leverage its operational strategies for sustainable growth.

Next FY Revenue

$36.06B

+3.5% YoY

SG&A Elasticity

1.04x

Model Accuracy

2.0% MAPE

Holdout validation: The model predicted $9B vs the actual $9B — an error of 3.3%.

Note: Medtronic Plc does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

Quarterly Detail

Quarter	Model Forecast	Actual	95% Range	YoY Growth	Status
Q1 2026	$9B	$9B	$8B – $9B	+3.8%	✓ In range
Q2 2026	$9B		$8B – $10B	+6.4%
Q3 2026	$9B		$8B – $10B	+4.3%
Q4 2026	$9B		$8B – $10B	+1.3%
Q1 2027	$9B		$8B – $10B	+2.1%

How Spending Drives Revenue

Reading this chart: Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch